000028 國藥一致
按盤價 
27.020 +0.600 (+2.271%)
27.020 +0.600 (+2.271%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 73,415,858 | -1.29% | 75,477,485 | 73,443,137 | 68,357,810 | 59,649,455 | |
| 減：營業總成本 | 71,812,830 | -1.65% | 73,277,097 | 71,309,688 | 66,519,747 | 57,817,567 | |
| 其中:營業成本 | 65,575,391 | -0.84% | 66,425,426 | 64,516,926 | 60,339,298 | 52,591,767 | |
| 財務費用 | 182,960 | -23.58% | 204,535 | 189,514 | 212,483 | 119,855 | |
| 資產減值損失 | (290,177) | -70.82% | (17,577) | (71,588) | (242,905) | (5,179) | |
| 公允價值變動收益 | 3,129 | -115.13% | (15,161) | 28,871 | -- | -- | |
| 投資收益 | 217,607 | -10.00% | 237,029 | 139,131 | 292,381 | 283,952 | |
| 其中：對聯營企業和合營企業的投資收益 | 315,684 | -14.61% | 315,446 | 298,527 | 333,397 | 354,346 | |
| 營業利潤 | 1,512,829 | 163.80% | 2,467,425 | 2,306,069 | 1,952,411 | 2,163,841 | |
| 利潤總額 | 1,509,020 | 162.22% | 2,473,227 | 2,311,070 | 1,974,853 | 2,157,236 | |
| 減：所得稅費用 | 380,672 | 12.47% | 514,739 | 539,332 | 447,211 | 435,940 | |
| 淨利潤 | 1,128,349 | 376.09% | 1,958,487 | 1,771,738 | 1,527,642 | 1,721,296 | |
| 減：非控股權益 | (7,578) | -98.13% | 359,231 | 285,030 | 191,214 | 319,404 | |
| 股東淨利潤 | 1,135,927 | 76.80% | 1,599,256 | 1,486,708 | 1,336,428 | 1,401,893 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 2.040 | 77.39% | 2.870 | 2.670 | 3.120 | 3.270 | |
| 每股派息 (元) * | 0.616 | 68.31% | 0.680 | 0.800 | 0.600 | 0.800 | |
| 每股淨資產 (元) * | 33.437 | 5.32% | 31.290 | 37.666 | 34.861 | 32.580 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 02/04/2026 13:00 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
